An ALK translocation positive carcinoma of the lung presenting as uremia due to bilateral

Auteurs-es

  • Shilo Rosenberg Hebrew University, Hadassah Medical Organization
  • Ran Katz
  • Dov Pode
  • N. Ofer Gofr

DOI :

https://doi.org/10.5489/cuaj.172

Mots-clés :

lung adenocarcinoma malignant retroperitoneal fibrosis crizotinib

Résumé

We describe an unusual presentation of metastatic lung adenocarcinoma as malignant retroperitoneal fibrosis (MRPF). The diagnostic challenge, due to the small solitary lung mass and absence of a discrete retroperitoneal mass, was overcome by diagnostic laparoscopy. Molecular analysis of tissue acquired was positive for ALK gene rearrangement. Treatment of the patient with crizotinib reversed MRPF. He was weaned off the nephrostomy tubes and is with stable renal function 11 months after diagnosis.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Biographie de l'auteur-e

Shilo Rosenberg, Hebrew University, Hadassah Medical Organization

Urology, senior urologist

Téléchargements

Publié-e

2013-07-02

Comment citer

Rosenberg, S., Katz, R., Pode, D., & Gofr, N. O. (2013). An ALK translocation positive carcinoma of the lung presenting as uremia due to bilateral. Canadian Urological Association Journal, 7(7-8), E490–4. https://doi.org/10.5489/cuaj.172

Numéro

Rubrique

Case Report